Meet us at ICPE

8 August 2019

We’ll be at the 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) in Philadelphia from 26 to 28 August 2019.

Look out for our oral and poster presentations listed below.

You can also meet members of our Observational Research and Business Development teams at our exhibition booth #1107, including Dr Puja Myles our Head of Observational Research.

If you would like to set up a meeting please send through any specific questions you would like to discuss and the time/days that you are available to bm@cprd.com by Tuesday 20 August. We will then get back to you to confirm timings.

Oral presentation

CPRD will be presenting session 4: UK CPRD experience with prescribing data formatted to the Sentinel Common Data Model at the following joint symposium with FDA, CNODES and the Sentinel Operating Centre:

Thinking Globally While Acting Locally: Developing Time-on-treatment Data in International Settings
Date/time: Monday 26 August, 3.30pm to 5pm
Publication number: # 44 Room: 201 B

Posters

Feasibility of Using Electronic Health Records to Identify Patients with Chronic Obstructive Pulmonary Disease to Enrol into Pragmatic Trials
Title: Poster Session A: Trials
Date/time: Monday 26 August, 8am to 6pm
Publication number: 408 Room: Hall A

Expanding Primary Care Coverage with CPRD Aurum
Title: Poster Session A: Databases
Date/time: Monday 26 August, 8am to 6pm
Publication number: 218 Room: Hall A

Lifestyle Factors and Systemic Breast Cancer Treatment – a Cross-sectional UK Study
Title: Poster Session A: Drug Effectiveness – Cancer
Date/time: Monday 26 August, 8am to 6pm
Publication number: 253 Room: Hall A

Area-level Linkages to Enrich Primary Care Electronic Health Data for Research
Title: Poster Session B: Databases
Date/time: Tuesday 27 August, 8am to 5pm
Publication number: 501 Room: Hall A

Other posters to look out for include:

Case Validation of Cutaneous Lymphomas to Minimize Protopathic Bias
Title: Poster Session B: Methods - Study Design, Bias, and Confounding
Date/time: Tuesday 27 August, 8am to 6pm
Publication number: 645 Room: Hall A

Risk Minimization Effectiveness for Mirabegron in the Netherlands, Spain, UK and Finland
Title: Poster Session C: Benefit-Risk Assessment, Communication, and Evaluation
Date/time: Wednesday 28 August, 8am to 3pm
Publication number: 951 Room: Hall A